Cargando…

Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications

Plasma cell dyscrasias are a heterogeneous group of diseases characterized by the expansion of bone marrow plasma cells. Malignant transformation of plasma cells depends on the continuity of events resulting in a sequence of well-defined disease stages, from monoclonal gammopathy of undetermined sig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salomon-Perzyński, Aleksander, Jamroziak, Krzysztof, Głodkowska-Mrówka, Eliza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469181/ https://www.ncbi.nlm.nih.gov/pubmed/34573876 http://dx.doi.org/10.3390/diagnostics11091534

Ejemplares similares

Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2022)

Immunochemotherapy for Richter syndrome: current insights
por: Puła, Bartosz, et al.
Publicado: (2019)

Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma
por: Bianchi, Giada, et al.
Publicado: (2014)

CRL4(CRBN) E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma
por: Barankiewicz, Joanna, et al.
Publicado: (2022)

Treatment Strategies Considering Micro-Environment and Clonal Evolution in Multiple Myeloma
por: Suzuki, Kazuhito, et al.
Publicado: (2021)

Molecular and immunological mechanisms of clonal evolution in multiple myeloma
por: Forster, Stefan, et al.
Publicado: (2023)

FoxP3 Tregs Response to Sublingual Allergen Specific Immunotherapy in Children Depends on the Manifestation of Allergy
por: Stelmaszczyk-Emmel, Anna, et al.
Publicado: (2015)

P393: GENETIC CHARACTERISTICS OF PEDIATRIC B-OTHER ACUTE LYMPHOBLASTIC LEUKEMIA COHORT USING TARGETED RNA SEQUENCING
por: Głodkowska-Mrówka, Eliza, et al.
Publicado: (2023)

PB1710: AN EXTENDED FLOW CYTOMETRY PANEL AS A SCREENING TOOL FOR PH-LIKE ALL
por: Cieloch, Adrianna, et al.
Publicado: (2023)

PB2062: PAROXYSMAL NOCTURNAL HEMOGLOBINURIA SCREENING AFTER INTRODUCTION OF HIGH-SENSITIVITY DIAGNOSTICS – A SINGLE-CENTER 10-YEAR EXPERIENCE
por: Głodkowska-Mrówka, Eliza, et al.
Publicado: (2023)

The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple Myeloma
por: Sandmann, Sarah, et al.
Publicado: (2022)

Dynamic Changes in the Ability to Release Neutrophil ExtraCellular Traps in the Course of Childhood Acute Leukemias
por: Ostafin, Magdalena, et al.
Publicado: (2021)

P656: NOVEL THIAZOLIDINEDIONE WITH HDAC INHIBITING PROPERTIES OPTIMIZED FOR CHRONIC MYELOID LEUKEMIA TREATMENT
por: Rams, Anna, et al.
Publicado: (2023)

Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications
por: Saoudi González, Nadia, et al.
Publicado: (2023)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming
por: Liang, Yuanzheng, et al.
Publicado: (2022)

The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients
por: Barankiewicz, Joanna, et al.
Publicado: (2021)

Immunophenotypic Characteristics of Bone Marrow Microenvironment Cellular Composition at the Biochemical Progression of Multiple Myeloma
por: Krzywdzińska, Agnieszka, et al.
Publicado: (2022)

Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stability
por: Dutta, Ankit K., et al.
Publicado: (2018)

Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence
por: Misund, Kristine, et al.
Publicado: (2022)

Bone Disease in Multiple Myeloma: Biologic and Clinical Implications
por: Bernstein, Zachary S., et al.
Publicado: (2022)

Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH
por: Yan, Yuting, et al.
Publicado: (2022)

Implications of Heterogeneity in Multiple Myeloma
por: de Mel, Sanjay, et al.
Publicado: (2014)

Gene Expression Profiling Predicts Sensitivity of Chronic Lymphocytic Leukemia Cells to Dasatinib
por: Blätte, Tamara J., et al.
Publicado: (2020)

Insights into IGH clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications
por: Darzentas, Franziska, et al.
Publicado: (2023)

Endothelial progenitor cells display clonal restriction in multiple myeloma
por: Braunstein, Marc, et al.
Publicado: (2006)

Harmonization of Flow Cytometric Minimal Residual Disease Assessment in Multiple Myeloma in Centers of Polish Myeloma Consortium
por: Krzywdzińska, Agnieszka, et al.
Publicado: (2021)

The Evolution of Prognostic Factors in Multiple Myeloma
por: Hanbali, Amr, et al.
Publicado: (2017)

A Stepwise Screening Protocol for Multiple Myeloma
por: Morawska, Marta, et al.
Publicado: (2023)

Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant
por: Mouhieddine, Tarek H., et al.
Publicado: (2020)

Monoubiquitinated Fanconi Anemia D2 (FANCD2-Ub) Is Required for BCR-ABL1 Kinase -Induced Leukemogenesis
por: Koptyra, Mateusz, et al.
Publicado: (2011)

Advances in diagnostics and therapy of systemic amyloidoses
por: Jamroziak, Krzysztof, et al.
Publicado: (2020)

Chromosomal Aberrations Associated with Clonal Evolution and Leukemic Transformation in Fanconi Anemia: Clinical and Biological Implications
por: Meyer, Stefan, et al.
Publicado: (2012)

PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells
por: Glodkowska-Mrowka, E, et al.
Publicado: (2016)

The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications
por: Puła, Anna, et al.
Publicado: (2021)

Insights on Multiple Myeloma Treatment Strategies
por: Mateos, María-Victoria, et al.
Publicado: (2018)

Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance
por: Melaccio, Assunta, et al.
Publicado: (2022)

Co-evolution of Immune Response in Multiple Myeloma: Implications for Immune Prevention
por: McCachren, Samuel S., et al.
Publicado: (2021)

Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications
por: Cresswell, George D., et al.
Publicado: (2016)

The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patients
por: Shires, Karen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5qmg5h5nnqb8f0h97j2i3lbuof